Tiverton Asset Management LLC Cuts Holdings in DENTSPLY SIRONA Inc (NASDAQ:XRAY)

Tiverton Asset Management LLC trimmed its holdings in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 87.9% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,947 shares of the medical instruments supplier’s stock after selling 14,124 shares during the quarter. Tiverton Asset Management LLC’s holdings in DENTSPLY SIRONA were worth $113,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Hanseatic Management Services Inc. purchased a new position in DENTSPLY SIRONA during the first quarter valued at approximately $30,000. Altshuler Shaham Ltd increased its holdings in DENTSPLY SIRONA by 209.8% during the second quarter. Altshuler Shaham Ltd now owns 505 shares of the medical instruments supplier’s stock valued at $30,000 after buying an additional 342 shares during the period. Cornerstone Advisors Inc. increased its holdings in DENTSPLY SIRONA by 62.0% during the second quarter. Cornerstone Advisors Inc. now owns 904 shares of the medical instruments supplier’s stock valued at $53,000 after buying an additional 346 shares during the period. Van ECK Associates Corp purchased a new position in DENTSPLY SIRONA during the second quarter valued at approximately $54,000. Finally, Arcadia Investment Management Corp MI purchased a new position in DENTSPLY SIRONA during the second quarter valued at approximately $58,000. 94.66% of the stock is currently owned by institutional investors.

XRAY traded up $0.76 during trading on Thursday, hitting $51.89. The stock had a trading volume of 65,120 shares, compared to its average volume of 1,758,120. The company has a market capitalization of $11.46 billion, a PE ratio of 25.85, a PEG ratio of 1.86 and a beta of 0.99. DENTSPLY SIRONA Inc has a twelve month low of $33.93 and a twelve month high of $59.40. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.39 and a current ratio of 2.08. The stock has a 50 day simple moving average of $52.69 and a two-hundred day simple moving average of $52.82.



DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Friday, August 2nd. The medical instruments supplier reported $0.66 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.62 by $0.04. The company had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $1.04 billion. DENTSPLY SIRONA had a net margin of 2.67% and a return on equity of 9.19%. DENTSPLY SIRONA’s revenue was down 3.1% compared to the same quarter last year. During the same period last year, the firm earned $0.60 earnings per share. On average, equities research analysts anticipate that DENTSPLY SIRONA Inc will post 2.39 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 11th. Stockholders of record on Friday, September 27th will be paid a dividend of $0.10 per share. This is an increase from DENTSPLY SIRONA’s previous quarterly dividend of $0.09. This represents a $0.40 annualized dividend and a dividend yield of 0.77%. The ex-dividend date is Thursday, September 26th. DENTSPLY SIRONA’s payout ratio is presently 17.41%.

Several equities analysts recently issued reports on the stock. ValuEngine lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Wellington Shields raised shares of DENTSPLY SIRONA from a “hold” rating to a “gradually accumulate” rating in a report on Friday, August 2nd. Evercore ISI began coverage on shares of DENTSPLY SIRONA in a research note on Friday, July 26th. They issued an “in-line” rating for the company. Zacks Investment Research downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and set a $62.00 target price for the company. in a research note on Monday, May 27th. Finally, Barrington Research restated a “buy” rating and issued a $63.00 target price on shares of DENTSPLY SIRONA in a research note on Monday, August 5th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and four have given a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $54.57.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Featured Article: Operating Income

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.